CNS trials
Next Steps to Treat Parkinson’s, Huntington’s and Alzheimer’s Disease
February 01 by Helen WinsorJoachim Tedroff, Head of Clinical Science at NeuroSearch Sweden AB, joins Helen Winsor from Pharma IQ, to discuss strategies for optimising clinical development in CNS. First Tedroff outlines what h...
Cutting Attrition Rates in Your CNS Clinical Trials
January 07 by Helen WinsorDr. Wolfgang Eglmeier, Head of Clinical Operations Germany, Grünenthal GmbH, joins Helen Winsor from Pharma IQ, to discuss optimising clinical development in CNS. He outlines the main challenges when...